| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| COLES & BODOIN LLP | 2,107 | 0 | 0 | 2,107 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| VANGUARD DEVELOPED MARKETS | 297,972 | 470,051 |
| VANGUARD EMERGING MARKETS | 184,665 | 325,187 |
| VANGUARD EUROPEAN STOCK MKT | 0 | 0 |
| CVS | 0 | 0 |
| MCKESSON | 0 | 0 |
| ALKERMES | 0 | 0 |
| MEDCO | 246,316 | 579,300 |
| VANGUARD 500 INDEX FUND | 623,403 | 679,960 |
| VANGUARD EUR STOCK INDEX | 885,252 | 1,040,793 |
| VANGUARD PAC STOCK INDEX | 626,904 | 647,453 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| MA FILING FEE | 125 | 0 | 0 | 125 |
| OFFICE | 153 | 0 | 0 | 0 |